Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
81 | Food and Drug Law Journal | journal | 0.171 Q4 | 23 | 0 | 43 | 0 | 35 | 42 | 0.89 | 0.00 | 0.00 | |
80 | Human gene therapy methods | journal | 0.920 Q2 | 38 | 0 | 80 | 0 | 240 | 80 | 2.14 | 0.00 | 0.00 | |
79 | Journal of Biomolecular Screening | journal | 0.907 Q2 | 86 | 0 | 13 | 0 | 40 | 12 | 0.00 | 0.00 | 0.00 | |
78 | National Toxicology Program technical report series | journal | 0.108 | 22 | 2 | 7 | 0 | 1 | 7 | 0.20 | 0.00 | 0.00 | |
77 | NTP Immunotoxicity Technical Report Series | book series | 0 | 3 | 0 | 335 | 0 | 0 | 0.00 | 111.67 | 46.15 | ||
76 | Journal of Experimental Therapeutics and Oncology | journal | 0.163 Q4 | 40 | 5 | 77 | 116 | 48 | 77 | 0.50 | 23.20 | 35.71 | |
75 | Adverse Drug Reaction Bulletin | journal | 0.101 Q4 | 8 | 6 | 20 | 197 | 0 | 17 | 0.00 | 32.83 | 40.00 | |
74 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 29 | 7 | 25 | 793 | 51 | 0 | 2.38 | 113.29 | 5.56 | ||
73 | Topics in antiviral medicine | journal | 0.935 Q2 | 46 | 9 | 54 | 99 | 149 | 50 | 2.66 | 11.00 | 42.86 | |
72 | Current Protocols in Pharmacology | journal | 0.893 Q2 | 39 | 11 | 44 | 290 | 114 | 44 | 2.50 | 26.36 | 50.00 | |
71 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.730 Q2 | 82 | 18 | 43 | 2951 | 201 | 43 | 4.93 | 163.94 | 36.76 | |
70 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 25 | 106 | 1660 | 69 | 106 | 0.74 | 66.40 | 33.33 | |
69 | Pharmacological Reviews | journal | 8.176 Q1 | 254 | 26 | 65 | 10316 | 1412 | 65 | 22.15 | 396.77 | 37.50 | |
68 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | 44.51 | |
67 | Annual Review of Pharmacology and Toxicology | journal | 4.968 Q1 | 224 | 33 | 90 | 4408 | 1273 | 90 | 13.16 | 133.58 | 38.60 | |
66 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.206 Q4 | 34 | 35 | 98 | 1201 | 97 | 98 | 0.86 | 34.31 | 38.30 | |
65 | Cannabis and Cannabinoid Research | journal | 1.156 Q1 | 42 | 40 | 95 | 1657 | 676 | 91 | 5.24 | 41.43 | 45.90 | |
64 | Current Therapeutic Research | journal | 0.449 Q3 | 46 | 43 | 71 | 1512 | 145 | 63 | 1.71 | 35.16 | 41.46 | |
63 | Journal of Immunotherapy | journal | 1.805 Q1 | 106 | 46 | 147 | 1371 | 734 | 147 | 4.52 | 29.80 | 44.44 | |
62 | Vascular Pharmacology | journal | 1.479 Q1 | 108 | 47 | 204 | 2358 | 1061 | 202 | 5.45 | 50.17 | 43.56 | |
61 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 0.827 Q2 | 70 | 48 | 162 | 2283 | 346 | 155 | 2.07 | 47.56 | 40.00 | |
60 | Clinical Neuropharmacology | journal | 0.486 Q3 | 85 | 49 | 179 | 1149 | 286 | 165 | 1.32 | 23.45 | 35.38 | |
59 | Hospital Pharmacy | journal | 0.309 Q3 | 28 | 58 | 260 | 1663 | 263 | 218 | 0.83 | 28.67 | 46.05 | |
58 | Neuropsychopharmacology Reports | journal | 0.661 Q2 | 22 | 60 | 69 | 1623 | 134 | 68 | 1.94 | 27.05 | 22.97 | |
57 | Prostaglandins and Other Lipid Mediators | journal | 0.810 Q2 | 86 | 61 | 164 | 4398 | 516 | 163 | 3.07 | 72.10 | 41.19 | |
56 | Experimental and Clinical Psychopharmacology | journal | 1.066 Q1 | 101 | 68 | 192 | 4274 | 492 | 190 | 2.54 | 62.85 | 48.75 | |
55 | Journal of NeuroImmune Pharmacology | journal | 1.219 Q1 | 91 | 69 | 162 | 6473 | 611 | 149 | 3.23 | 93.81 | 40.89 | |
54 | Journal of Pharmacological and Toxicological Methods | journal | 0.353 Q3 | 83 | 69 | 220 | 2766 | 455 | 217 | 1.79 | 40.09 | 38.50 | |
53 | Biologicals | journal | 0.503 Q3 | 66 | 75 | 238 | 2222 | 456 | 233 | 1.84 | 29.63 | 42.16 | |
52 | Behavioural Pharmacology | journal | 0.711 Q2 | 87 | 78 | 223 | 4341 | 500 | 215 | 2.14 | 55.65 | 48.39 | |
51 | Journal of Biopharmaceutical Statistics | journal | 0.557 Q3 | 56 | 79 | 256 | 2110 | 185 | 244 | 0.74 | 26.71 | 32.39 | |
50 | Medicinal Research Reviews | journal | 2.868 Q1 | 150 | 81 | 162 | 16520 | 2023 | 160 | 12.29 | 203.95 | 36.31 | |
49 | Drug and Chemical Toxicology | journal | 0.422 Q3 | 54 | 85 | 206 | 4209 | 479 | 206 | 2.47 | 49.52 | 44.71 | |
48 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.716 Q2 | 68 | 89 | 189 | 3174 | 507 | 183 | 2.52 | 35.66 | 37.89 | |
47 | Journal of AOAC International | journal | 0.432 Q3 | 100 | 94 | 742 | 2779 | 1139 | 710 | 1.58 | 29.56 | 38.99 | |
46 | Reading Teacher | journal | 0.642 Q2 | 60 | 94 | 297 | 2131 | 329 | 258 | 1.06 | 22.67 | 80.35 | |
45 | Journal of Ocular Pharmacology and Therapeutics | journal | 0.727 Q2 | 72 | 98 | 279 | 3626 | 616 | 254 | 2.23 | 37.00 | 35.92 | |
44 | Medical Letter on Drugs and Therapeutics | journal | 0.246 Q3 | 22 | 100 | 321 | 531 | 138 | 179 | 0.55 | 5.31 | 0.00 | |
43 | International Journal of Medicinal Mushrooms | journal | 0.471 Q3 | 41 | 110 | 307 | 3926 | 654 | 305 | 2.00 | 35.69 | 44.57 | |
42 | Molecular Pharmacology | journal | 1.469 Q1 | 210 | 118 | 398 | 6658 | 1521 | 396 | 3.88 | 56.42 | 41.86 | |
41 | American Journal of Therapeutics | journal | 0.349 Q3 | 69 | 127 | 535 | 3030 | 515 | 235 | 0.83 | 23.86 | 44.04 | |
40 | Chirality | journal | 0.430 Q3 | 83 | 130 | 322 | 5093 | 711 | 319 | 2.27 | 39.18 | 32.56 | |
39 | Therapeutic Drug Monitoring | journal | 0.649 Q2 | 102 | 130 | 303 | 4819 | 827 | 284 | 2.86 | 37.07 | 44.05 | |
38 | ACS Pharmacology and Translational Science | journal | 2.271 Q1 | 36 | 132 | 64 | 8523 | 223 | 56 | 3.48 | 64.57 | 38.38 | |
37 | U.S. Pharmacist | trade journal | 0.129 Q4 | 12 | 133 | 356 | 1451 | 61 | 232 | 0.18 | 10.91 | 54.87 | |
36 | Basic and Clinical Pharmacology and Toxicology | journal | 0.805 Q2 | 103 | 137 | 513 | 5816 | 1488 | 488 | 3.13 | 42.45 | 43.49 | |
35 | Cancer Biology and Therapy | journal | 1.166 Q1 | 130 | 141 | 425 | 5232 | 1759 | 421 | 4.11 | 37.11 | 42.04 | |
34 | Steroids | journal | 0.469 Q3 | 114 | 141 | 438 | 6408 | 1060 | 433 | 2.59 | 45.45 | 44.34 | |
33 | Addiction Biology | journal | 1.445 Q1 | 93 | 142 | 367 | 7636 | 1468 | 363 | 3.59 | 53.77 | 45.47 | |
32 | Anti-Cancer Drugs | journal | 0.651 Q2 | 102 | 144 | 375 | 4354 | 881 | 374 | 2.15 | 30.24 | 41.46 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®